Sara Lara, NP-C

NPI: 1326408386
Total Payments
$7,666
2024 Payments
$3,471
Companies
30
Transactions
320
Medicare Patients
3,156
Medicare Billing
$172,332

Payment Breakdown by Category

Food & Beverage$7,509 (97.9%)
Education$157.69 (2.1%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,509 317 97.9%
Education $157.69 3 2.1%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,469 54 $0 (2024)
Insmed, Inc. $817.26 27 $0 (2024)
GlaxoSmithKline, LLC. $639.81 42 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $592.31 23 $0 (2024)
Inspire Medical Systems, Inc. $529.76 6 $0 (2024)
United Therapeutics Corporation $381.31 12 $0 (2024)
Actelion Pharmaceuticals US, Inc. $375.84 28 $0 (2024)
GENZYME CORPORATION $373.58 13 $0 (2024)
Mylan Specialty L.P. $342.78 18 $0 (2024)
Regeneron Healthcare Solutions, Inc. $249.89 10 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,471 123 AstraZeneca Pharmaceuticals LP ($644.87)
2023 $1,806 78 Insmed, Inc. ($286.60)
2022 $2,059 110 AstraZeneca Pharmaceuticals LP ($451.88)
2021 $329.33 9 AstraZeneca Pharmaceuticals LP ($156.88)

All Payment Transactions

320 individual payment records from CMS Open Payments — Page 1 of 13

Date Company Product Nature Form Amount Type
12/30/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $22.18 General
Category: RESPIRATORY
12/17/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $15.45 General
Category: IMMUNOLOGY
12/12/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $31.53 General
Category: Respiratory
12/11/2024 Merck Sharp & Dohme LLC ZERBAXA (Drug) Food and Beverage In-kind items and services $22.61 General
Category: INFECTIOUS DISEASE
12/09/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $24.08 General
Category: RESPIRATORY
12/05/2024 Takeda Pharmaceuticals U.S.A., Inc. HYQVIA (Biological) Food and Beverage In-kind items and services $27.28 General
Category: IMMUNOLOGY
12/04/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $29.65 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
12/03/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $15.28 General
Category: Respiratory
12/03/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $13.40 General
Category: RESPIRATORY
11/21/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $15.28 General
Category: IMMUNOLOGY
11/20/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $34.06 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
11/20/2024 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $17.07 General
Category: HFCWO
11/14/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $17.38 General
Category: Respiratory
11/13/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $25.44 General
Category: INFLAMMATION AND IMMUNOLOGY
11/12/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $31.31 General
Category: Respiratory
11/11/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $21.62 General
Category: RESPIRATORY
11/07/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug), UPTRAVI Food and Beverage In-kind items and services $20.70 General
Category: Cardiology
11/06/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $22.78 General
Category: Respiratory
11/05/2024 Grifols USA, LLC Prolastin-C Liquid (Biological) Food and Beverage In-kind items and services $29.55 General
Category: Pulmonology
10/31/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $21.16 General
Category: Immunology
10/30/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $34.06 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
10/28/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $17.50 General
Category: Respiratory
10/28/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $14.13 General
Category: Respiratory
10/17/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $30.42 General
Category: RESPIRATORY
10/17/2024 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $19.94 General
Category: HFCWO

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 832 902 $154,053 $57,058
2022 7 570 620 $109,031 $38,057
2021 11 677 709 $83,033 $36,200
2020 21 1,077 1,166 $128,088 $41,016
Total Patients
3,156
Total Services
3,397
Medicare Billing
$172,332
Procedure Codes
50

All Medicare Procedures & Services

50 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 404 462 $80,850 $36,680 45.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 100 108 $24,300 $12,293 50.6%
94729 Test to examine how well the lungs exchange gases Office 2023 54 54 $8,208 $1,854 22.6%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Office 2023 65 65 $12,025 $1,510 12.6%
94727 Test to determine lung volumes using gas dilution or washout Office 2023 56 56 $5,656 $1,492 26.4%
G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) Office 2023 48 49 $3,577 $1,113 31.1%
94618 Test for exercise-induced lung stress Office 2023 42 43 $15,050 $919.77 6.1%
99441 Telephone medical discussion with physician, 5-10 minutes Office 2023 15 16 $1,232 $565.60 45.9%
94010 Test to measure expiratory airflow and volume Office 2023 18 18 $1,782 $283.56 15.9%
99406 Smoking and tobacco use intensive counseling, 4-10 minutes Office 2023 17 17 $561.00 $200.77 35.8%
94664 Evaluation of use of breathing device Office 2023 13 14 $812.00 $145.88 18.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 368 417 $72,465 $29,724 41.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 39 39 $8,775 $4,412 50.3%
94729 Test to examine how well the lungs exchange gases Office 2022 35 35 $5,320 $1,212 22.8%
94727 Test to determine lung volumes using gas dilution or washout Office 2022 38 39 $3,774 $939.29 24.9%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Office 2022 35 35 $6,475 $811.22 12.5%
94618 Test for exercise-induced lung stress Office 2022 27 27 $9,450 $537.46 5.7%
94010 Test to measure expiratory airflow and volume Office 2022 28 28 $2,772 $420.57 15.2%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 144 153 $24,085 $11,886 49.4%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 68 68 $16,320 $6,931 42.5%
87635 Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2021 114 117 $11,700 $6,003 51.3%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 91 96 $10,591 $5,118 48.3%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 72 72 $11,920 $4,832 40.5%
71046 X-ray of chest, 2 views Office 2021 21 25 $2,500 $492.43 19.7%
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count Office 2021 44 49 $2,009 $380.73 19.0%

About Sara Lara, NP-C

Sara Lara, NP-C is a Family healthcare provider based in Little River, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2016. The National Provider Identifier (NPI) number assigned to this provider is 1326408386.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sara Lara, NP-C has received a total of $7,666 in payments from pharmaceutical and medical device companies, with $3,471 received in 2024. These payments were reported across 320 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($7,509).

As a Medicare-enrolled provider, Lara has provided services to 3,156 Medicare beneficiaries, totaling 3,397 services with total Medicare billing of $172,332. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Little River, SC
  • Active Since 03/03/2016
  • Last Updated 10/20/2021
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1326408386

Products in Payments

  • Arikayce (Drug) $793.19
  • DUPIXENT (Biological) $623.47
  • OFEV (Drug) $532.44
  • INSPIRE (Device) $529.76
  • TRELEGY ELLIPTA (Drug) $495.92
  • FASENRA (Biological) $406.93
  • BREZTRI (Drug) $352.22
  • TEZSPIRE (Biological) $311.74
  • OPSUMIT (Drug) $265.57
  • ACTHAR (Biological) $233.95
  • AIRSUPRA (Drug) $225.83
  • TYVASO (Drug) $216.54
  • (8874) inCourage (Device) $200.75
  • YUPELRI (Drug) $179.48
  • Hillrom - Life 2000 Ventilation System (Device) $169.10
  • Yupelri (Drug) $163.30
  • SMARTVEST (Device) $146.13
  • IMFINZI (Biological) $133.64
  • NUCALA (Biological) $126.10
  • Da Vinci Surgical System (Device) $117.23

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Little River